Home » Topics » Conferences

Conferences
RSS

News from ASH: lisofylline in BMT

Dec. 10, 1998

CMA-676 shows efficacy and excellent tolerability in patients with AML

Dec. 9, 1998

Excellent results obtained in AML patients receiving Maxamine plus IL-2

Dec. 9, 1998

Banyu conducts PK and metabolic studies of topoisomerase I inhibitor

Dec. 9, 1998

Cerus presents preclinical data on RBC pathogen inactivation system and begins clinical trials

Dec. 9, 1998

Preliminary report of therapeutic efficacy with 506U78 in leukemia patients

Dec. 8, 1998

Hughes Institute studying BTK-specific inhibitor LFM-A13

Dec. 8, 1998

Xcellerate-based therapy shows promising results in otherwise untreatable cancer patients

Dec. 8, 1998

PSC-833 plus chemotherapy is safe and effective in older patients with AML

Dec. 7, 1998

Bracco announces approval and launch of second-generation MRI contrast agent

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...